Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease

Individuals with chronic kidney disease are at an increased risk for cardiovascular disease. This risk may partially be explained by a chronic inflammatory state in these patients, reflected by increased arterial wall and cellular inflammation. Statin treatment decreases cardiovascular risk and arte...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoogeveen, Renate M., Verweij, Simone L., Kaiser, Yannick, Kroon, Jeffrey, Verberne, Hein J., Vogt, Liffert, Moens, Sophie J. Bernelot, Stroes, Erik S. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892998/
https://www.ncbi.nlm.nih.gov/pubmed/33602971
http://dx.doi.org/10.1038/s41598-021-83273-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892998/
https://www.ncbi.nlm.nih.gov/pubmed/33602971
http://dx.doi.org/10.1038/s41598-021-83273-2

Ejemplares similares